Back
iShares LifePath Target Date 2040 ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
64
ITDD
iShares LifePath Target Date 2040 ETF
Last Price:
$35.99
Seasonality Move:
2.42%
Sell
20
NVO
Novo Nordisk A/S
Last Price:
$48.11
Seasonality Move:
4.04%
Buy
64
iShares LifePath Target Date 2040 ETF (ITDD)
is a Buy
Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?
-
The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.57. The Score for ITDD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
ITDD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $47.61. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ITDD Stock Price Chart
What is iShares LifePath Target Date 2040 ETF's stock price today?
-
The iShares LifePath Target Date 2040 ETF share price today is $35.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.61Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
ITDD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 51.71 | Buy |
| Chaikin Money Flow: | -10404 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 44.82 | Sell |
| Chaikin Money Flow: | -6318846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ITDD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.66 | Sell |
| 20-day SMA: | 35.51 | Buy |
| 50-day SMA: | 35.4 | Buy |
| 200-day SMA: | 33.15 | Buy |
| 8-day EMA: | 35.6 | Sell |
| 20-day EMA: | 35.55 | Buy |
| 50-day EMA: | 35.32 | Buy |
| 200-day EMA: | 33.65 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.82 | Sell |
| 20-day SMA: | 48.1 | Sell |
| 50-day SMA: | 50.21 | Sell |
| 200-day SMA: | 61.08 | Sell |
| 8-day EMA: | 48.51 | Sell |
| 20-day EMA: | 48.56 | Sell |
| 50-day EMA: | 50.31 | Sell |
| 200-day EMA: | 63.25 | Sell |
iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.16 per share.
iShares LifePath Target Date 2040 ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||